Lista de obras - Homie Razavi - Dominio Público Uruguay

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

artículo científico publicado en 2012

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

artículo científico publicado en 2011

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

artículo científico publicado en 2011

Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data

artículo científico publicado en 2011

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study

article

Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland.

artículo científico publicado en 2015

Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment

artículo científico publicado en 2016

Chronic hepatitis C virus (HCV) burden in Rhode Island: modelling treatment scale-up and elimination

artículo científico publicado en 2016

Chronic hepatitis C virus (HCV) disease burden and cost in the United States

artículo científico publicado en 2013

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

artículo científico publicado en 2012

Disease burden of chronic hepatitis C in Brazil

artículo científico publicado en 2015

Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies

artículo científico publicado en 2015

Economic burden of hepatitis C-associated diseases in the United States.

artículo científico publicado en 2011

Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas

artículo científico publicado en 2012

Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply

artículo científico publicado en 2020

Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System

artículo científico publicado en 2017

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

artículo científico publicado en 2014

Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift.

artículo científico publicado en 2016

Estimating HCV disease burden - volume 3 (editorial).

artículo científico publicado en 2015

Estimating the Health Impact of Vaccination Against 10 Pathogens in 98 Low and Middle Income Countries from 2000 to 2030

artículo científico publicado en 2019

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

Forecasting the disease burden of chronic hepatitis C virus in Poland

artículo científico publicado en 2015

Global epidemiology and genotype distribution of the hepatitis C virus infection

artículo científico publicado en 2014

Global genotype distribution of hepatitis C viral infection among people who inject drugs

artículo científico publicado en 2016

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

artículo científico publicado en 2018

Global timing of hepatitis C virus elimination in high-income countries

artículo científico publicado en 2019

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

artículo científico publicado en 2015

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition

artículo científico publicado en 2015

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

artículo científico publicado en 2014

HCV infection prevalence in a population recruited at health centers in Jordan

article

Hepatitis C virus infection

artículo científico publicado en 2017

Hepatitis C virus infection in Argentina: Burden of chronic disease.

artículo científico publicado en 2016

Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia

artículo científico publicado en 2016

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

artículo científico publicado en 2015

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.

artículo científico publicado en 2015

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

artículo científico publicado en 2014

Historical epidemiology of hepatitis C virus in select countries—volume 4

artículo científico publicado en 2017

Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost‐effectiveness model

artículo científico publicado en 2023

Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.

artículo científico publicado en 2016

Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden

scientific article published on 14 June 2016

Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world

scientific article published in 2021

Making the case for looking beyond WHO estimates for the global burden of hepatitis C and B.

artículo científico publicado en 2016

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland

artículo científico publicado en 2015

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

artículo científico

Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models

artículo científico publicado en 2020

Optimization of hepatitis C virus screening strategies by birth cohort in Italy

artículo científico publicado en 2020

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis

artículo científico publicado en 2016

Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study

artículo científico

Progress towards hepatitis C virus elimination in high-income countries: an updated analysis

scientific article published on 02 January 2021

Response to Taiwan is on track of accelerating hepatitis C elimination by 2025

scientific article published on 24 April 2020

Response to letter to the editor: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue

artículo científico publicado en 2014

Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey

artículo científico publicado en 2017

Securing sustainable funding for viral hepatitis elimination plans

scientific article published on 05 December 2019

Strategies to manage hepatitis C virus (HCV) disease burden.

artículo científico publicado en 2014

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.

artículo científico publicado en 2015

Strategies to manage hepatitis C virus infection disease burden - volume 3.

artículo científico publicado en 2015

Strategies to manage hepatitis C virus infection disease burden—Volume 4

artículo científico publicado en 2017

The case for simplifying and using absolute targets for viral hepatitis elimination goals

scientific article published on 26 September 2020

The cost effectiveness of hepatitis C virus elimination in low and middle-income countries

artículo científico publicado en 2020

The current and future disease burden of chronic hepatitis C virus infection in Egypt

artículo científico

The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies

artículo científico publicado en 2014

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

artículo científico publicado en 2014

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.

artículo científico publicado en 2015

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.

artículo científico publicado en 2015

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4

artículo científico publicado en 2017

Trends and projections of hepatitis C virus epidemiology in Latin America.

artículo científico publicado en 2011

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

scholarly article

Lista de obras de Homie Razavi

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study

Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland.

Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment

Chronic hepatitis C virus (HCV) burden in Rhode Island: modelling treatment scale-up and elimination

Chronic hepatitis C virus (HCV) disease burden and cost in the United States

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Disease burden of chronic hepatitis C in Brazil

Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies

Economic burden of hepatitis C-associated diseases in the United States.

Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas

Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply

Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift.

Estimating HCV disease burden - volume 3 (editorial).

Estimating the Health Impact of Vaccination Against 10 Pathogens in 98 Low and Middle Income Countries from 2000 to 2030

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

Forecasting the disease burden of chronic hepatitis C virus in Poland

Global epidemiology and genotype distribution of the hepatitis C virus infection

Global genotype distribution of hepatitis C viral infection among people who inject drugs

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

Global timing of hepatitis C virus elimination in high-income countries

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

HCV infection prevalence in a population recruited at health centers in Jordan

Hepatitis C virus infection

Hepatitis C virus infection in Argentina: Burden of chronic disease.

Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Historical epidemiology of hepatitis C virus in select countries—volume 4

Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost‐effectiveness model

Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.

Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden

Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world

Making the case for looking beyond WHO estimates for the global burden of hepatitis C and B.

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models

Optimization of hepatitis C virus screening strategies by birth cohort in Italy

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis

Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study

Progress towards hepatitis C virus elimination in high-income countries: an updated analysis

Response to Taiwan is on track of accelerating hepatitis C elimination by 2025

Response to letter to the editor: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end-stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue

Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey

Securing sustainable funding for viral hepatitis elimination plans

Strategies to manage hepatitis C virus (HCV) disease burden.

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.

Strategies to manage hepatitis C virus infection disease burden - volume 3.

Strategies to manage hepatitis C virus infection disease burden—Volume 4

The case for simplifying and using absolute targets for viral hepatitis elimination goals

The cost effectiveness of hepatitis C virus elimination in low and middle-income countries

The current and future disease burden of chronic hepatitis C virus infection in Egypt

The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4

Trends and projections of hepatitis C virus epidemiology in Latin America.

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010